The business of life sciences came into sharp focus after the pandemic highlighted the effectiveness of mRNA vaccines in protecting people against COVID. But what exactly is life sciences and is the recent market weakness a threat to future innovation — or an opportunity? In the latest episode of Exchanges at Goldman Sachs, Amit Sinha, head of Life Sciences ... Show More
Jul 8
The Surprising Implications of an Aging Population
An aging global population has long been viewed as a demographic time bomb. Kevin Daly, co-head of the Central and Eastern Europe, Middle East, and Africa economics team at Goldman Sachs Research, explains why this concern may be overstated. This episode was recorded on May 29, 2 ... Show More
15m 49s
Jul 1
Commodities Outlook: What’s Driving Oil, Gold, and Base Metals
Goldman Sachs’ Daan Struyven discusses how recent geopolitical events and evolving tariff policies are affecting the commodity and economic landscape. This episode was recorded on June 30, 2025. Learn more about your ad choices. Visit megaphone.fm/adchoices
19m 28s
Jun 23
Mid-year outlook: diversify and hedge
Goldman Sachs’ Christian Mueller-Glissmann, head of asset allocation research in Goldman Sachs Research, and Alexandra Wilson-Elizondo, co-head and co-chief investment officer of the Multi-Asset Solutions business in Goldman Sachs Asset Management, examine the dynamics driving ma ... Show More
24m 23s
Oct 2020
How actuaries can carry insurtech forward
TRANSCRIPT: https://actuaries.logicaldoc.cloud:443/download-ticket?ticketId=3de6a82a-77f8-42ce-98da-3acdcb3771d8
DESCRIPTION: In the latest Actuaries Institute podcast, Angat Sandhu virtually interviews Annette King, chair and co-founder of Galileo Platforms, to discuss the forma ... Show More
17m 11s
Sep 2023
Business and science: How risky is SynBio?
For all the exciting developments in the synthetic biology industry, there are also concerns. People can edit genes in their garages these days, so who’s regulating this space?Plus - we’ll hear about the exciting new business models with biology at their core, including one of th ... Show More
17m 26s
Nov 2022
Stephan Kessler: What Does the Future Hold for ESG Investing?
Critics of sustainable investing have said that Environmental, Social, and Governance strategies require investors to sacrifice long-term returns, but is this really the case?
----- Transcript -----
Welcome to Thoughts on the Market. I'm Stephan Kessler, Morgan Stanley's Global H ... Show More
3m 29s
Sep 2023
The intersection of technology and healthcare
Private markets have grown significantly over the past few years, fueled by scientific breakthroughs and technological innovation. Our experts discuss biotechnology, artificial intelligence and healthcare valuation trends, how venture capitalists and startups are navigating the c ... Show More
25m 15s
Feb 2023
Healthspan, Lifespan, and the Biology of Aging
In this cross-over episode from Bio Eats World, Kristen Fortney, cofounder and CEO of BioAge, joins Vijay Pande, founding partner of a16z Bio + Health, and Olivia Webb, editorial lead, to discuss the biology of aging, how she started a company, and some fun things — like how long ... Show More
36m 45s